2009 Midyear New-Build Update: Pharmaceutical-Biotech Industry Completes Construction of 40 North American Facilities
2009 Midyear New-Build Update: Pharmaceutical-Biotech Industry Completes Construction of 40 North American Facilities
Attachment: IIR Chart - New Pharma and Biotech Plants
SUGAR LAND--June 24, 2009--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The first six months of one of the toughest years in recent history are almost over. A recent analysis of new builds for the North American Pharmaceutical-Biotech Industry has revealed some surprisingly positive news in the form of 40 new manufacturing plants and research centers. Every market region has enjoyed the addition of at least one new site becoming operational during the first six months of this year.
Other companies featured: Bristol-Myers Squibb Company's (NYSE:BMY), Laboratory Corporation of America (NYSE:LH)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs